In last trading session, TG Therapeutics Inc. (NASDAQ:TGTX) saw 3.83 million shares changing hands with its beta currently measuring 1.96. Company’s recent per share price
TG Therapeutics Inc. (NASDAQ:TGTX) has a beta value of 1.96 and has seen 3.1 million shares traded in the last trading session. The company, currently
During the last session, TG Therapeutics Inc. (NASDAQ:TGTX)’s traded shares were 2.79 million, with the beta value of the company hitting 1.97. At the end
In the last trading session, 5.24 million shares of the TG Therapeutics Inc. (NASDAQ:TGTX) were traded, and its beta was 1.97. Most recently the company’s
TG Therapeutics Inc. (NASDAQ:TGTX)’s traded shares stood at 9.22 million during the last session, with the company’s beta value hitting 1.98. At the close of
In the latest trading session, 1.46 million TG Therapeutics Inc. (NASDAQ:TGTX) shares changed hands as the company’s beta touched 1.98. With the company’s most recent
In last trading session, TG Therapeutics Inc. (NASDAQ:TGTX) saw 6.28 million shares changing hands with its beta currently measuring 2.12. Company’s recent per share price
TG Therapeutics Inc. (NASDAQ:TGTX) has a beta value of 2.12 and has seen 23.05 million shares traded in the last trading session. The company, currently
During the last session, TG Therapeutics Inc. (NASDAQ:TGTX)’s traded shares were 32.61 million, with the beta value of the company hitting 2.18. At the end
In the last trading session, 3.88 million shares of the TG Therapeutics Inc. (NASDAQ:TGTX) were traded, and its beta was 2.18. Most recently the company’s